Session

PP 05 IBD (Posters)

THE PREDICTIVE VALUE OF IRON DEFICIENCY ANAEMIA AND THE SEVERITY OF ANAEMIA ON THE ONE-YEAR DISEASE COURSE OF INFLAMMATORY BOWEL DISEASE
THE PREDICTIVE VALUE OF IRON DEFICIENCY ANAEMIA AND THE SEVERITY OF ANAEMIA ON THE ONE-YEAR DISEASE COURSE OF INFLAMMATORY BOWEL DISEASE

SYSTEMIC INFLAMMATORY PROTEIN PROFILES OF INFLAMMATORY BOWEL DISEASE PATIENTS - A PRELIMINARY STUDY
SYSTEMIC INFLAMMATORY PROTEIN PROFILES OF INFLAMMATORY BOWEL DISEASE PATIENTS - A PRELIMINARY STUDY

LONG TERM PERSISTENCE OF USTEKINUMAB IN CROHN’S DISEASE: CLINICAL OUTCOMES AND PROGNOSTIC FACTORS
LONG TERM PERSISTENCE OF USTEKINUMAB IN CROHN’S DISEASE: CLINICAL OUTCOMES AND PROGNOSTIC FACTORS

SYSTEMATIC REVIEW AND META-ANALYSIS: PSYCHOLOGICAL THERAPIES ARE ASSOCIATED WITH SHORT-TERM IMPROVEMENTS IN PSYCHOLOGICAL HEALTH IN INFLAMMATORY BOWEL DISEASE
SYSTEMATIC REVIEW AND META-ANALYSIS: PSYCHOLOGICAL THERAPIES ARE ASSOCIATED WITH SHORT-TERM IMPROVEMENTS IN PSYCHOLOGICAL HEALTH IN INFLAMMATORY BOWEL DISEASE

RISK FACTORS OF MALIGNANCIES IN INFLAMMATORY BOWEL DISEASE: A SINGLE CENTER EXPERIENCE
RISK FACTORS OF MALIGNANCIES IN INFLAMMATORY BOWEL DISEASE: A SINGLE CENTER EXPERIENCE

THE DEPENDENCE OF THE LEVEL OF GLYCOPROTEIN TYPE 2 ON THE LEVEL OF ZONULIN IN CROHN'S DISEASE
THE DEPENDENCE OF THE LEVEL OF GLYCOPROTEIN TYPE 2 ON THE LEVEL OF ZONULIN IN CROHN'S DISEASE

DISEASE OUTCOMES CAN BE PREDICTED BY MEMBERSHIP OF NOVEL SYMPTOM CLUSTERS IN INFLAMMATORY BOWEL DISEASE: RESULTS FROM A PROSPECTIVE LONGITUDINAL FOLLOW-UP STUDY
DISEASE OUTCOMES CAN BE PREDICTED BY MEMBERSHIP OF NOVEL SYMPTOM CLUSTERS IN INFLAMMATORY BOWEL DISEASE: RESULTS FROM A PROSPECTIVE LONGITUDINAL FOLLOW-UP STUDY

BIOELECTRICAL IMPEDANCE ANALYSIS REVEALED DIFFERENCES BETWEEN LEAN AND NON-LEAN NON-ALCOHOLIC FATTY LIVER DISEASE IN PATIENTS WITH CROHN’S DISEASE
BIOELECTRICAL IMPEDANCE ANALYSIS REVEALED DIFFERENCES BETWEEN LEAN AND NON-LEAN NON-ALCOHOLIC FATTY LIVER DISEASE IN PATIENTS WITH CROHN’S DISEASE

VITAMIN DEFICIENCIES IN CROHN'S DISEASE
VITAMIN DEFICIENCIES IN CROHN'S DISEASE

COLONIC EPITHELIAL BRUSH BORDER ALTERATIONS IN MICROSCOPIC COLITIS: AN INTEGRATED MULTI-OMIC ANALYSIS
COLONIC EPITHELIAL BRUSH BORDER ALTERATIONS IN MICROSCOPIC COLITIS: AN INTEGRATED MULTI-OMIC ANALYSIS

ALTERED EXPRESSION AND ENZYMATIC ACTIVITY OF XANTHINE OXIDASE IN INFLAMMATORY BOWEL DISEASE
ALTERED EXPRESSION AND ENZYMATIC ACTIVITY OF XANTHINE OXIDASE IN INFLAMMATORY BOWEL DISEASE

TRANSCRIPTOM​​​​IC PROFILING OF LYMPHOCYTIC COLITIS HIGHLIGHTS DISTINCT DIARRHOEAL PATHOMECHANISMS COMPARED TO OTHER INFLAMMATORY BOWEL DISEASES
TRANSCRIPTOM​​​​IC PROFILING OF LYMPHOCYTIC COLITIS HIGHLIGHTS DISTINCT DIARRHOEAL PATHOMECHANISMS COMPARED TO OTHER INFLAMMATORY BOWEL DISEASES

GRANULOCYTE BIOMARKERS IN STOOL AND SERUM AND THEIR ASSOCIATION WITH DISEASE ACTIVITY AND LOCALIZATION IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE
GRANULOCYTE BIOMARKERS IN STOOL AND SERUM AND THEIR ASSOCIATION WITH DISEASE ACTIVITY AND LOCALIZATION IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE

EFFICACY OF ANTI-TUMOR NECROSIS FACTOR ALPHA THERAPY IN INTESTINAL BEHÇET’S DISEASE
EFFICACY OF ANTI-TUMOR NECROSIS FACTOR ALPHA THERAPY IN INTESTINAL BEHÇET’S DISEASE

USING MACHINE LEARNING METHODS, CAN ANTIBIOTICS PREDICT A FUTURE RELAPSE IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE? – A POPULATION-BASED NESTED CASE-CONTROL STUDY USING MACHINE LEARNING METHODS
USING MACHINE LEARNING METHODS, CAN ANTIBIOTICS PREDICT A FUTURE RELAPSE IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE? – A POPULATION-BASED NESTED CASE-CONTROL STUDY USING MACHINE LEARNING METHODS

THE USE OF ANTIBIOTICS INCREASES THE RISK OF RELAPSE IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE – A POPULATION-BASED NESTED CASE-CONTROL STUDY USING THE DANISH NATIONAL PATIENT REGISTRY
THE USE OF ANTIBIOTICS INCREASES THE RISK OF RELAPSE IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE – A POPULATION-BASED NESTED CASE-CONTROL STUDY USING THE DANISH NATIONAL PATIENT REGISTRY

SERIC HAPTOGLOBIN KINETICS MAY PREDICT CLINICAL OUTCOME IN PATIENTS WITH IBD UNDERGOING BIOLOGICS
SERIC HAPTOGLOBIN KINETICS MAY PREDICT CLINICAL OUTCOME IN PATIENTS WITH IBD UNDERGOING BIOLOGICS

NATURAL HISTORY AND IMPACT OF IRRITABLE BOWEL SYNDROME-TYPE SYMPTOMS IN INFLAMMATORY BOWEL DISEASE DURING ONE-YEAR OF LONGITUDINAL FOLLOW UP
NATURAL HISTORY AND IMPACT OF IRRITABLE BOWEL SYNDROME-TYPE SYMPTOMS IN INFLAMMATORY BOWEL DISEASE DURING ONE-YEAR OF LONGITUDINAL FOLLOW UP

THE ROAD TO AND SEQUENCE OF BIOLOGICAL THERAPY IN A POPULATION-BASED, EUROPEAN INCEPTION COHORT OF PATIENTS WITH INFLAMMATORY BOWEL DISEASE -AN EPI-IBD COHORT STUDY
THE ROAD TO AND SEQUENCE OF BIOLOGICAL THERAPY IN A POPULATION-BASED, EUROPEAN INCEPTION COHORT OF PATIENTS WITH INFLAMMATORY BOWEL DISEASE -AN EPI-IBD COHORT STUDY

TISSUE MICRO-RNAS AS MARKERS OF EARLY DIAGNOSIS AND MONITORING OF COLORECTAL CANCER IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE
TISSUE MICRO-RNAS AS MARKERS OF EARLY DIAGNOSIS AND MONITORING OF COLORECTAL CANCER IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE

Item 641 - 660 / 826
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32
33
34 35 36 37 38 39 40 41 42